Key result
The provided text is a library recommendation form and does not contain clinical research data.
Why the study?
Does perindopril reduce VEGF-mediated tumor development and angiogenesis in murine hepatocellular carcinoma models?
Does perindopril reduce VEGF-mediated tumor development and angiogenesis in murine hepatocellular carcinoma models?
Inhibition of the renin-angiotensin system with perindopril attenuates VEGF-mediated tumor development and angiogenesis in a murine model.
No takes yet. Share an insight, caveat, or question.
Perindopril attenuates VEGF-mediated angiogenesis in murine HCC; hypothesis-generating and requires clinical validation before any therapeutic consideration.
Yoshiji et al. (2002) studied this question. The provided text is a library recommendation form and does not contain clinical research data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: